lb-100

Small moleculeexperimental

Chemistry & pharmacology

Loading structure…

SMILES

CN1CCN(C(=O)C2C(C(=O)O)[C@H]3CC[C@@H]2O3)CC1
Mol. weight
268.31 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • lb-100
  • lb-100

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06012734Phase 1Dec 31, 2023Netherlands Cancer Institute
NCT06065462Phase 1/Phase 2 (Phase 2)Nov 10, 2023University of Texas at Houston
NCT05809830Phase 1/Phase 2 (Phase 2)May 29, 2023Grupo Espanol de Investigacion en Sarcomas, Universidad Autonoma de Madrid
NCT04560972Phase 1Nov 8, 2020City of Hope National Medical Center, National Cancer Institute (NCI)
NCT03886662Phase 1/Phase 2 (Phase 2)Apr 30, 2019Lixte Biotechnology Holdings, Inc., University of South Florida
NCT03027388Early Phase 1 (Phase 1)Jan 5, 2017National Cancer Institute (NCI)
NCT01837667Phase 1Feb 1, 2013Baylor University, City of Hope National Medical Center, Comprehensive Cancer Centers of Nevada, Lixte Biotechnology Holdings, Inc., Mayo Clinic
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
City of Hope National Medical CenterAcademic/Hospital2112013
Lixte Biotechnology Holdings, Inc.For profit2222013
National Cancer Institute (NCI)Government2112017
Baylor UniversityAcademic/Hospital1012013
Comprehensive Cancer Centers of NevadaAcademic/Hospital1012013
Grupo Espanol de Investigacion en SarcomasAcademic/Hospital1112023
Mayo ClinicAcademic/Hospital1012013
Netherlands Cancer InstituteAcademic/Hospital1112023
Universidad Autonoma de MadridAcademic/Hospital1012023
University of South FloridaAcademic/Hospital1012019
University of Texas at HoustonAcademic/Hospital1112023
11 organizations
Page 1 / 1